Physician profile
Joanne M Cox
NPI 1962481796
$1,035.14
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $393 · 2020: $106 · 2021: $536.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $190.38 | 2019-2021 | |
| Therapeuticsmd, INC. | $85.19 | 2019-2021 | |
| Coopersurgical, INC. | $71.10 | 2019-2021 | |
| Hologic Sales and Service, LLC | $62.88 | 2021 | |
| Daiichi Sankyo INC. | $62.49 | 2019-2021 | |
| Evofem Biosciences, INC. | $56.22 | 2021 | |
| Allergan, INC. | $51.96 | 2019 | |
| Exeltis, USA INC. | $49.85 | 2019-2021 | |
| Avion Pharmaceuticals | $45.14 | 2020-2021 | |
| Amgen INC. | $43.54 | 2019-2021 | |
| Radius Health, INC. | $42.28 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.20 | 2019-2020 | |
| Agile Therapeutics, INC. | $33.44 | 2021 | |
| Mayne Pharma Commercial LLC | $31.29 | 2021 | |
| Avanos Medical | $29.34 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $27.68 | 2019 | |
| Astellas Pharma US INC | $19.98 | 2019 | |
| Ascend Therapeutics US, LLC | $18.00 | 2021 | |
| Pfizer INC. | $17.93 | 2021 | |
| Merck Sharp & Dohme LLC | $15.53 | 2019 | |
| Millicent US INC | $15.30 | 2019 | |
| Mylan Pharmaceuticals INC. | $14.88 | 2021 | |
| Vertical Pharmaceuticals, LLC | $11.54 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joanne Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.